Comparing two PET scans to find insulinoma tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares two similar PET/CT scan agents to see which one better finds insulinomas — small tumors in the pancreas that cause low blood sugar. If you're scheduled for surgery, the results might help your doctor pinpoint the tumor before the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have symptoms and blood tests that strongly suggest you have an insulinoma.
- You must be scheduled to have surgery or a biopsy to confirm the diagnosis within 30 days after the scans.
- You must be able to undergo two PET/CT scans about a week apart.
- You cannot be pregnant, breastfeeding, or have serious liver or kidney problems that would make the scans risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (a 3D imaging test) to look for cancer cells that have GLP-1 receptors, a protein on some tumors. It aims to see if this scan can help find or monitor cancer.
This study uses a special PET scan to find areas in the pancreas that are making too much insulin, which can cause low blood sugar. The scan may help doctors plan surgery to remove these spots and improve blood sugar control.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
This study uses a special PET scan to measure how well insulin-producing cells (“beta cells”) in the pancreas are working in people with diabetes. It’s meant to help researchers understand diabetes biology and test whether the scan can reflect beta cell function.
This Phase 2 study uses special PET/MRI imaging to better understand a cause of hyperinsulinemic low blood sugar and guide whether surgery may help. It may help doctors choose the safest plan to reduce severe episodes and protect the brain.
This study tests a new imaging agent (68Ga-FAPI-46) to see if it can better show the extent of pancreatic cancer before surgery. It may help doctors plan your surgery more accurately.
Hear when a new Insulinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.